Feasibility of an Activity Regimen in Patients With Advanced Stage Lung Cancer
| Status: | Recruiting |
|---|---|
| Conditions: | Lung Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | 21 - Any |
| Updated: | 2/9/2019 |
| Start Date: | November 26, 2018 |
| End Date: | May 2020 |
| Contact: | Brett Bade, M.D. |
| Email: | brett.bade@yale.edu |
| Phone: | 203 785 3207 |
Assessing the Feasibility of a Patient-centered Activity Regimen in Patients With Advanced Stage Lung Cancer
The investigators will evaluate the feasibility of implementing a low-intensity,
patient-centered activity regimen (PCAR) that prioritizes education and communication over a
12-week period in advanced stage lung cancer patients. The primary outcomes will include
number of patients increasing their overall step count over the study period and adherence to
step count recommendations. Secondary outcomes will include quality of life (QoL), dyspnea,
and depression scores before and after the intervention as well as a patient feedback
questionnaire (to guide further interventions). The goals are to increase overall step count
and obtain adherence of >50% of participants. The investigators will also assess whether the
physical activity regimen influences markers of inflammation and glucose control and novel
markers of cancer.
patient-centered activity regimen (PCAR) that prioritizes education and communication over a
12-week period in advanced stage lung cancer patients. The primary outcomes will include
number of patients increasing their overall step count over the study period and adherence to
step count recommendations. Secondary outcomes will include quality of life (QoL), dyspnea,
and depression scores before and after the intervention as well as a patient feedback
questionnaire (to guide further interventions). The goals are to increase overall step count
and obtain adherence of >50% of participants. The investigators will also assess whether the
physical activity regimen influences markers of inflammation and glucose control and novel
markers of cancer.
Inclusion Criteria:
- Pathologic evidence of advanced non-small cell stage lung cancer (NSCLC)
- Approval of the treating clinician
- Adult patients (age >21 years) willing to wear a FitBit® device (FitBit, Inc., San
Francisco, CA)
- Access to a smartphone, agree to receive twice/daily text messages for 12 weeks
(including any costs), and willingness to download the FitBit application to their
smartphone.
- Low activity level as judged by a brief physical activity questionnaire (i.e., <150
minutes/week of moderate-intensity exercise, <75 minutes/week of vigorous aerobic
exercise, or an equivalent combination).
Exclusion Criteria:
- Memory impairment (as judged by the treating clinician)
- Communication impairment (as judged by the treating clinician)
- Treating clinician's request not to alter physical activity
- Physical inability to safely walk (as judged by the treating clinician)
We found this trial at
1
site
Yale University Yale's roots can be traced back to the 1640s, when colonial clergymen led...
Click here to add this to my saved trials
